IL6 and Huntington disease: Our findings suggest that increased insulin resistance (HOMA-IR), oxidative stress (ADMA, HDL), and inflammation (IL-6) due to AO are independently associated with PAD in HD patients, which are not analyzed in previous studies [8]–[9].